Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Hyperkalemia: Pharmacotherapies And Clinical Considerations, Evan S. Sinnathamby, Kelly T. Banh, William T. Barham, Tyler D. Hernandez, Audrey J. De Witt, Danielle M. Wenger, Vincent G. Klapper, David Mcgregor, Antonella Paladini, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye, Giustino Varrassi
Hyperkalemia: Pharmacotherapies And Clinical Considerations, Evan S. Sinnathamby, Kelly T. Banh, William T. Barham, Tyler D. Hernandez, Audrey J. De Witt, Danielle M. Wenger, Vincent G. Klapper, David Mcgregor, Antonella Paladini, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye, Giustino Varrassi
School of Medicine Faculty Publications
Hyperkalemia has been defined as a condition where a serum potassium level is > 5.5 mmol/l. It is associated with fatal dysrhythmias and muscular dysfunction. Certain medical conditions, such as chronic kidney disease (CKD), diabetes mellitus, and others, can lead to hyperkalemia. Many of the signs of hyperkalemia are nonspecific. A history and physical examination can be beneficial in the diagnosis of the condition. In this regard, certain characteristic electrocardiogram findings are associated with hyperkalemia along with laboratory potassium levels. In acute and potentially lethal conditions, hyperkalemia treatments include glucose and insulin, bicarbonate, calcium gluconate, beta-2 agonists, hyperventilation, and dialysis. There …
Evaluation Of Serum Magnesium Differences In Hypertensive Crises And Control Patients: A Randomly Matched Case-Control Study, Ifeanyi Chukwu O. Onor, Emily K. Johnston, Nicole G. Little, Lashira M. Hill, Oluwabunmi E. Lawal, Casey J. Payne, Mallory R. Coleman, Carolkim H. Huynh, Sarah E. Bilbe, Ahlam A. Ayyad, Kabrea J. Jones, Jasmine D. Kinnard, Rosanna Dastoori, Devinn K. Rolland, Amanda S. Miller, Robbie A. Beyl, Christopher J. Gillard, John I. Okogbaa, Daniel F. Sarpong, Rim M. Hadgu, Amne Borghol, Samuel C. Okpechi, Mihran V. Naljayan, Shane E. Sanno, Shane G. Guillory
Evaluation Of Serum Magnesium Differences In Hypertensive Crises And Control Patients: A Randomly Matched Case-Control Study, Ifeanyi Chukwu O. Onor, Emily K. Johnston, Nicole G. Little, Lashira M. Hill, Oluwabunmi E. Lawal, Casey J. Payne, Mallory R. Coleman, Carolkim H. Huynh, Sarah E. Bilbe, Ahlam A. Ayyad, Kabrea J. Jones, Jasmine D. Kinnard, Rosanna Dastoori, Devinn K. Rolland, Amanda S. Miller, Robbie A. Beyl, Christopher J. Gillard, John I. Okogbaa, Daniel F. Sarpong, Rim M. Hadgu, Amne Borghol, Samuel C. Okpechi, Mihran V. Naljayan, Shane E. Sanno, Shane G. Guillory
School of Medicine Faculty Publications
Although the role of magnesium in blood pressure has been well studied among hypertensive patients, no study has explored the role of magnesium in hypertensive crises. The primary objective of this study is to evaluate the differences in serum magnesium levels between hypertensive crises patients and matched controls (age-, sex-, race-, and diabetes-matched) in a 1:1 random match. This study is a single-center, retrospective, chart review, case-control study of patients with hypertensive crises (case group) and patients without hypertensive crises (control group). Patients were included in the case group if they were 18 years of age or older with hypertensive …